V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003331 | 210012866 | 1.65 | 57 | Adjuvant (A) | 2021-03-06 | 2021-03-06 | Docetaxel | 02 | N | DOCETAXEL | 101718877 |
| 210003333 | 210012867 | 1.54 | 75.6 | Neo-adjuvant (N) | 2019-12-19 | 2020-04-05 | Docetaxel | 02 | N | DOCETAXEL | 100273998 |
| 210003336 | 210012869 | 1.55 | 0 | Neo-adjuvant (N) | 2017-05-09 | 2017-07-19 | Docetaxel | 02 | Y | DOCETAXEL | 100446841 |
| 210003339 | 210012870 | 1.56 | 55.3 | Palliative (P) | 2017-05-29 | 2017-05-31 | Trastuzumab | 02 | N | TRASTUZUMAB | 101171326 |
| 210003341 | 210012871 | 1.63 | 82.9 | Adjuvant (A) | 2019-08-26 | 2019-09-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101829987 |
| 210003344 | 210012873 | 1.62 | 114 | Adjuvant (A) | 2018-01-11 | 2018-03-30 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100143902 |
| 210003348 | 210012874 | 1.75 | 57.7 | Neo-adjuvant (N) | null | 2021-06-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100405639 |
| 210003352 | 210012875 | 1.63 | 57 | null | null | 2017-07-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100260471 |
| 210003353 | 210012876 | 1.56 | 50.4 | null | null | 2019-07-26 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100093309 |
| 210003354 | 210012877 | 1.64 | 73.3 | Adjuvant (A) | null | 2019-01-18 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101398167 |
| 210003358 | 210012879 | 1.73 | 67 | null | 2016-04-02 | 2017-05-07 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100534008 |
| 210003359 | 210012880 | 1.52 | null | Adjuvant (A) | 2013-05-09 | 2013-07-10 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101038709 |
| 210003367 | 210012882 | 1.64 | 78 | Adjuvant (A) | 2018-12-12 | 2019-11-30 | Docetaxel | null | N | DOCETAXEL | 101819454 |
| 210003370 | 210012883 | 1.66 | 71.6 | Curative (C) | 2021-03-04 | 2021-08-02 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100300042 |
| 210003372 | 210012884 | 1.64 | 72 | null | 2019-05-05 | 2019-06-29 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100784396 |
| 210003374 | 210012885 | null | 75.9 | Neo-adjuvant (N) | 2019-06-16 | 2019-06-18 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100104750 |
| 210003376 | 210012886 | 1.66 | 103 | Adjuvant (A) | null | 2020-12-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101648428 |
| 210003380 | 210012887 | 1.58 | 76.8 | Curative (C) | 2019-03-23 | 2019-10-26 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100381088 |
| 210003383 | 210012888 | 1.67 | 59.1 | Adjuvant (A) | 2021-06-06 | 2021-06-17 | Docetaxel | 02 | N | DOCETAXEL | 101405068 |
| 210003388 | 210012889 | 1.68 | 58.1 | Adjuvant (A) | 2017-08-11 | 2017-10-23 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101361613 |
| 210003393 | 210012890 | 1.56 | 67.15 | Palliative (P) | null | 2019-07-08 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101536249 |
| 210003396 | 210012891 | null | 77.2 | Neo-adjuvant (N) | 2019-03-27 | 2019-04-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101333374 |
| 210003400 | 210012892 | null | null | null | 2020-02-18 | 2020-05-05 | Docetaxel | null | N | DOCETAXEL | 101441451 |
| 210003411 | 210012894 | 1.7 | 97.7 | Adjuvant (A) | 2021-12-07 | 2022-03-10 | Paclitaxel 7 day | null | null | PACLITAXEL | 101557115 |
| 210003415 | 210012895 | null | 85.2 | Palliative (P) | 2018-01-05 | 2018-02-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 100289053 |
| 210003416 | 210012896 | 1.58 | 80.55 | null | 2021-06-18 | 2021-10-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101247313 |
| 210003421 | 210012899 | 1.79 | 56.9 | Adjuvant (A) | null | 2021-04-24 | Docetaxel | null | N | DOCETAXEL | 101291223 |
| 210003425 | 210012902 | 1.59 | 82 | Palliative (P) | 2020-12-26 | 2021-03-15 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100143422 |
| 210003426 | 210012903 | 1.62 | 73.3 | Adjuvant (A) | 2018-12-04 | 2018-12-25 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101846842 |
| 210003428 | 210012904 | 1.73 | 57 | Palliative (P) | 2021-03-02 | 2021-03-02 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100592120 |
| 210003429 | 210012905 | 1.57 | 99.4 | null | 2018-10-05 | 2019-02-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100147183 |
| 210003432 | 210012907 | 1.81 | 59.1 | Adjuvant (A) | 2021-12-09 | 2022-02-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101833996 |
| 210003434 | 210012908 | 1.56 | 72 | Adjuvant (A) | 2022-03-16 | 2022-04-23 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100341751 |
| 210003435 | 210012909 | 1.5 | 73.15 | Palliative (P) | 2020-12-13 | 2020-12-13 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101535177 |
| 210003436 | 210012910 | 1.58 | 72.8 | Palliative (P) | 2019-09-03 | 2019-09-09 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100136553 |
| 210003439 | 210012911 | 1.69 | 91.7 | Palliative (P) | null | 2020-03-01 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100457558 |
| 210003440 | 210012912 | null | 68.8 | null | 2019-08-12 | 2019-11-08 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PACLITAXEL | 101566652 |
| 210003451 | 210012914 | null | null | Neo-adjuvant (N) | 2018-08-27 | 2019-01-02 | Docetaxel | 02 | N | DOCETAXEL | 100951861 |
| 210003452 | 210012915 | 1.57 | 55.2 | Neo-adjuvant (N) | 2019-05-17 | 2019-12-29 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101775997 |
| 210003457 | 210012916 | 1.54 | 74.3 | Adjuvant (A) | null | 2021-02-20 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100233095 |
| 210003463 | 210012917 | 1.67 | 52 | Curative (C) | 2021-11-27 | 2021-12-09 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100494571 |
| 210003464 | 210012918 | 1.54 | 73.3 | Adjuvant (A) | 2018-07-04 | 2018-08-22 | Trastuzumab | 02 | N | TRASTUZUMAB | 101854779 |
| 210003467 | 210012919 | null | 59.8 | null | 2022-02-13 | 2022-02-13 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101178524 |
| 210003471 | 210012922 | null | 74.9 | Adjuvant (A) | 2021-05-20 | 2021-06-17 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100558104 |
| 210003472 | 210012923 | 1.77 | 80 | null | 2019-11-12 | 2020-01-29 | Docetaxel | null | null | DOCETAXEL | 101457043 |
| 210003473 | 210012924 | 1.63 | 76 | Palliative (P) | null | 2017-08-01 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100851270 |
| 210003483 | 210012926 | 1.39 | 71.1 | null | 2021-10-27 | 2021-11-05 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100054786 |
| 210003484 | 210012927 | 1.68 | 76.4 | Neo-adjuvant (N) | 2018-04-09 | 2018-07-18 | Trastuzumab | 02 | N | TRASTUZUMAB | 101074495 |
| 210003490 | 210012928 | 1.55 | 94 | Adjuvant (A) | 2020-06-25 | 2020-10-31 | Trastuzumab | 02 | null | TRASTUZUMAB | 100177487 |
| 210003491 | 210012929 | 1.57 | 67 | Adjuvant (A) | null | 2020-10-15 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100591677 |